Israeli Cardio-Oncology Society Virtual Meeting Preliminary Program

Total Page:16

File Type:pdf, Size:1020Kb

Israeli Cardio-Oncology Society Virtual Meeting Preliminary Program January 13-14, 2021 | Virtual Conference TOWARDS A COMPREHENSIVE CARDIAC-CANCER CARE Take this unique opportunity to join the ISCO 2021 conference and to effectively reach hundreds of cardiologists, oncologists and hemato-oncologists. Join us and present your research and technology to this influential and knowledgeable audience, and to have full access to all networking benefits. Conference secretariat - Dirigo Events & Conferences 3 Menorat Hamaor st. Tel-Aviv, Israel For more information, please contact: Tel: 03-7775485 | Email: [email protected] Yael Ziv Project Manager – Industry Liaison, Dirigo | Mobile: +972-54-5599821 | Email: [email protected] ISRAELI CARDIO-ONCOLOGY SOCIETY VIRTUAL MEETING PRELIMINARY PROGRAM Platinum Sponsorship Gold Sponsorship Silver Sponsorship January 13, 2021 15:45-16:00 Opening Session 15:45-15:47 Zaza Iakobishvili, Founder and Chair of the Meeting, Cardiology 15:47-15:49 Dan Gilon, Chair of the Meeting, Cardiology 15:49-15:51 David Sarid, Chair of the Meeting, Oncology 15:51-15:53 Martin Ellis, Chair of the Meeting, Hematology 15:53-15:55 Alex Lyon, ESC Cardio-Oncology Council 15:55-15:57 Bonnie Ky, JACC Cardio-Oncology 16:00-17:00 Plenary Session Chairs: Giorgio Minnotti, Faculty of Medicine and Surgery, Campus Bio-Medico University of Rome, Italy Alexander Battler, Chairman, Advisory Council on Cardiovascular Disease Management and Prevention, Ministry of Health, Israel 16:00-16:20 How to establish Cardio-Oncology collaboration Susan F. Dent, Associate Director of Breast Cancer Clinical Research, Co-Director Duke Cardio-Oncology Program, Durham, NC, USA 16:20-16:40 Guidelines in Cardio-Oncology: Gaps and Opportunities José Luis Zamorano, University Hospital Ramon Y Cajal, Madrid, Spain 16:40-17:00 Panel discussion: Future of Cardio-Oncology Richard H. Steingart, Chief of Cardiology Service, Memorial Sloan Kettering Cancer Center, NY, USA Teresa Lopez-Fernanadez, Cardio-Oncology Unit, La Paz University Hospital, Madrid Spain Hall A 17:00-17:45 Breast cancer: Recent Advances and Knowledge Gaps Chairs: Lior Gepstein, Rambam Health Care Campus, Haifa, Israel Noa Ben Baruch, Kaplan Medical Center, Rehovot, Israel 17:00-17:20 Advances in the Management of Metastatic Breast Cancer Rinat Yerushalmi, Davido Cancer Center, Petah Tikva, Israel Sponsored lecture: 17:20-17:35 Managing Cardiac Dysfunction Ana Barac, Georgetown University, Washington, DC, USA 17:35-17:45 Panel Discussion 17:45-18:30 Lung Cancer Chairs: Jacob George, Kaplan Medical Center, Rehovot, Israel Noam Asna, Barzilai Medical Center, Ashkelon, Israel 17:45-18:05 Overview of Recent Advances Nir Peled, Shaare Zedek Medical Center, Jerusalem, Israel 18:05-18:20 What Cardiologist Should know About the Lung Cancer? Tomas Neilan, Massachusetts General Hospital, University of Harvard, Boston, MA, USA 18:20-18:30 Panel Discussion 18:30-18:40 Coee Break 18:40-19:35 Genito-Urinary Cancer Chairs: Chaim Yose, Barzilai Medical Center, Ashkelon, Israel Raanan Berger, Sheba Medical Center, Tel Hashomer, Israel 18:40-19:00 Changing Landscape: Immunotherapy and Targeted Therapies VS. Traditional Treatment Raya Leibowitz, Shamir Medical Center, Be'er Ya'akov, Israel Sponsored lecture: 19:00-19:15 Cardiologist Role in the Management of GU Cancer Patients Darryl Leong, Population Health Research Institute, Hamilton, Ontario, Canada 19:15-19:25 Case Presentation Manhal Habib, Rambam Medical Center, Haifa, Israel 19:25-19:35 Panel Discussion 19:35-20:20 Gastro-Intestinal Tract Cancer Chairs: Joseph Carver, Hospital of the University of Pennsylvania, Philadelphia, PA, USA Irit Ben Aharon, Rambam Health Care Campus, Haifa, Israel 19:35-19:55 Changing Landscape: Immunotherapy and Targeted Therapies VS. Traditional Treatment Baruch Brenner, Davido Cancer Center, Petah Tikva, Israel 19:55-20:10 Approach of the Cardiologist Allison Padegimas, University of Pennsylvania, Philadelphia, Pennsylvania, USA 20:10-20:20 Panel Discussion 20:20-20:30 Coee Break 20:30-21:10 Atrial Fibrillation in Cancer Patients Chairs: Michael Glikson, Shaare Zedek Medical Center, Jerusalem, Israel Doron Zahger, Soroka Medical Center, Beer Sheva, Israel 20:30-20:45 Management of Anticoagulation Sebastian Szmit, Department of Pulmonary Circulation and Thromboembolic Diseases, Centre of Postgraduate Medical Education, European Health Centre Otwock, Otwock, Poland 20:45-21:00 Perspective of the Electrophysiologist Michael Fradley, University of Pennsylvania, Philadelphia, PA, USA 21:00-21:10 Panel Discussion 21:10-22:00 Precision Medicine in Cardio-Oncology I Chair: David Hasdai, Rabin Medical Center, Petah Tikva, Israel 21:10-21:25 Tailored Treatment in Heart Failure Michal Laufer-Perl, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel Sponsored lecture: 21:25-21:40 Lipid Lowering in Cancer Patients: Friend or Foe? Ohad Oren, Massachusetts General Hospital, MA, USA 21:40-22:00 Diabetes: Treat the Patient, not the Disease! Gideon Paul, Shamir Medical Center, Zerin, Israel Sponsored lecture: Hall B 17:00-17:40 Chronic Myeloid Leukemia: Frontline Therapy and Cardiovascular Issues Chairs: Pia Raanani, Rabin Medical Center, Petah Tikva, Israel Michael Arad, Sheba Medical Center, Tel Hashomer, Israel 17:00-17:15 Update on CML Adi Shacham, Rabin Medical Center, Petah Tikva, Israel Sponsored lecture: 17:15-17:30 Cardiologist's Approach to the CML Patient Javid Moslehi, Vanderbilt University Medical Center, TN, USA 17:30-17:40 Panel Discussion 17:40-18:25 Lymphomas Chairs: Majdi Halabi, Ziv Medical Center, Zefat, Israel TBA 17:40-17:55 Update on Lymphomas Uri Abadi, Meir Medical Center, Kfar-Saba, Israel 17:55-18:10 Cardio-Oncologist's Approach Arjun Ghosh, Barts Heart Center and UCLH, UK 18:10-18:25 Case Presentation and Panel Discussion Nati Horowitz, Rambam Medical Center, Haifa, Israel 18:25-18:35 Coee Break 18:35-19:40 Myeloma and Cardiac Amyloidosis Chairs: David Leibowitz, Hadassah-Hebrew University Medical Center, Jerusalem, Israel Arthur Pollak, Hadassah Medical Center, Jerusalem, Israel 18:35-18:50 Update on Myeloma and Cardiac AL Amyloidosis Moshe Gatt, Hadassah Medical Center, Jerusalem, Israel 18:50-19:05 Cardio-Oncologist's Approach Daniel J. Lenihan, Washington University Physicians, St. Louis, USA 19:05-19:25 Rediscovering Cardiac ATTR Amyloidosis Oren Caspi, Rambam Health Care Campus, Haifa, Israel Sponsored lecture: 19:25-19:40 Case Presentation and Panel Discussion Osnat Jarchowsky-Dolberg, Meir Medical Center,Kfar Saba, Israel 19:40-20:25 Leukemias Chairs: Doron Aronson, Rambam Medical Center, Haifa, Israel Ron Ram, Tel Aviv Sourasky Medical Center and Sackler Faculty, Tel Aviv University Israel 19:40-19:55 Update on Leukemias Moshe Yakir, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel 19:55-20:10 Chimeric Antigen Receptor T-Cell Therapy - How to Minimize Adverse Cardiovascular Eects Sarju Ganatra, Lahey Hospital & Medical Center, Burlington, MA, USA 20:10-20:25 Panel Discussion 20:25-20:35 Coee Break 20:35-21:20 Thrombosis and Cancer Chairs: David P. Dundua, Federal Research and Clinical Center FMBA, Russian Federation Eli I. Lev, Department of Cardiology, Samson Assuta Ashdod University Hospital, Ashdod, Israel 20:35-20:55 PE as a manifestation of Cancer Associated Thrombosis Shlomi Matetzky, Sheba Medical Center, Ramat Gan, Israel Sponsored lecture: 20:55-21:10 Approach of Clinical Pharmacologist Bruria Rakah, The Hebrew University of Jerusalem, Jerusalem, Israel 21:10-21:20 Panel Discussion January 14, 2021 Hall A 16:00-16:50 Radiation therapy Chairs: Alexander Sagie, Rabin Medical Center, Petah Tikva, Israel Ross A. Abrams, Hadassah Medical Center, Jerusalem, Israel 16:00-16:20 Modern Radiotherapy Amichay Meirovitz, Hadassah Medical Center, Jerusalem, Israel 16:20-16:40 Radiation-Associated Induced Cardiovascular Disease Prevention: How to do that? Tochi M. Okwuosa, Department of Internal Medicine, Rush Medical College, Chicago, IL, USA 16:40-16:50 Panel Discussion 16:50-17:35 Melanoma Chairs: Ariel Roguin, Hillel Yae Medical Center, Hadera, Israel Roni Shapira, Sheba Medical Center, Ramat-Gan, Israel 16:50-17:10 Overview of Recent Advances Gal Markel, Davidoff Medical Center, Petah Tikva, Israel 17:10-17:25 How to Mitigate Cardiovascular Risk and Complications? Dan Gilon, Hadassah-Hebrew University Medical Center, Jerusalem, Israel 17:25-17:35 Panel Discussion 17:35-18:20 Head and Neck Cancer Chairs: Shaul Atar, Galilee Medical Center, Nahariya, Israel Iris Gluck, Sheba Medical Center, Ramat-Gan, Israel 17:35-17:55 Overview of Recent Advances Aharon Popovtzer, Hadassah Medical Center, Jerusalem, Israel 17:55-18:10 What Cardiologist Should Know? Anju Nohria, Brigham and Women Hospital and Harvard University, Boston, MA, USA 18:10-18:20 Panel Discussion 18:20-18:30 Coee Break 18:30-19:15 Gynecologic Cancer Chairs: Avinoam Shiran, Carmel Medical Center, Haifa, Israel Ora Rosengarten, Shaare Zedek Medical Center, Jerusalem, Israel 18:30-18:50 New frontiers in Gyneco-Oncology Tamar Safra, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel 18:50-19:05 Cardiologist Approach to Mitigate Cardiovascular Risk and Complications Osnat Itzhaki, Rabin Medical Center, Petah Tikva, Israel 19:05-19:15 Panel Discussion 19:15-20:30 Sarcoma and GIST Chairs: Limor Ilan Bushari, Emek Medical Center, Afula, Israel Eytan Ben-Ami, Sheba Medical Center, Ramat-Gan, Israel 19:15-19:35 Beyond Traditional Chemotherapy Ofer Merimsky, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel 19:35-19:50 Cardiologist Role in the Management Dana Fourey, Sheba Medical Center, Ramat Gan, Israel 19:50-20:00
Recommended publications
  • Emergency in Israel
    Emergency in Israel Emergency Update on Jewish Agency Programming May 16, 2021 The recent violent events that have erupted across the country have left us all surprised and stunned: clashes with Palestinians in Jerusalem and on the Temple Mount; the deteriorating security tensions and the massive barrage of missiles from Gaza on southern and central Israel; and the outbreak of unprecedented violence, destruction, and lynching in mixed cities and Arab communities. To say that the situation is particularly challenging is an understatement. We must all deal with the consequences of the current tensions. Many of us are protecting family, coworkers, or people under our charge while missiles fall on our heads night and day, forcing us to seek shelter. We have all witnessed the unbearable sights of rioting, beating, and arson by Arab and Jewish extremists in Lod, Ramla, Acre, Kfar Qassem, Bat Yam, Holon, and other places. As an organization that has experienced hard times of war and destruction, as well as periods of prosperity and peace, it is our duty to rise up and make a clear statement: we will support and assist populations hit by missile fire as we did in the past, after the Second Lebanon War and after Operations Cast Lead and Protective Edge. Together with our partners, we will mobilize to heal and support the communities and populations affected by the fighting. Our Fund for Victims of Terror is already providing assistance to bereaved families. When the situation allows it, we will provide more extensive assistance to localities and communities that have suffered damage and casualties.
    [Show full text]
  • Scientific Program
    www.iscort.org.il Scientific Program 08.01.2019 - 12.01.2019, Eilat, Israel The Annual Meeting of The Israeli Society for Clinical Oncology and Radiation Therapy ISCORT wishes to express its gratitude to the following companies הוועדה המארגנת for their support of the 19th ISCORT Annual Meeting: Organizing Committee ISCORT 19 נשיא הכנס: :President פרופ׳ סלומון שטמר Platinum Sponsor Salomon M. Stemmer, MD Roche מזכירת הכנס: :Secretory ד״ר ולריה סמניסטי Gold Sponsor Valeria Semenysty, MD יו"ר הרדיותרפיה: :BMS Radiation Oncology Co-Chair פרופ׳ בן קורן MSD Ben W. Corn, MD הוועדה המדעית Silver Sponsor Scientific Committee ISCORT 19 Astellas יו"ר: פרופ׳ מיכל לוטם Astrazeneca Chairman: Michal Lotem, MD ד"ר אהרון אלון Boehringer Ingelheim Aaron Allen, MD ד"ר נועם אסנה Eli Lilly Noam Asna, MD ד"ר יאיר בר ISI Jair Bar, MD PhD ד"ר יהונתן כהן Novartis Yonathan Cohen, MD PhD פרופ׳ בן קורן Pfizer Ben W. Corn, MD ד"ר אלה עברון Rafa Ella Evron, MD ד"ר דניאלה כץ Daniela Katz, MD פרופ׳ גל מרקל Bronze Sponsor Gal Markel, MD PhD ד"ר אינה אוספובט AbbVie Inna Ospovat, MD ד"ר אביבית פאר Assuta Avivit Peer, MD ד"ר רות פרץ Bayer Ruth Perets, MD PhD Bolpharma ד"ר רפאל פפר Raphael Pfeffer, MD Dexcel Pharma ד"ר קרן רובינוב Keren Rouvinov, MD Isotopia ד"ר יקטרינה שולמן Katerina Shulman, MD Medison ד"ר אמיר זוננבליק Merck Amir Sonnenblick, MD ד"ר מרק ויגודה Nanostring Marc Wygoda, MD ד"ר אלונה זר Neopharm Alona Zer, MD ד"ר אביעד זיק Oncotest-Teva Aviad Zik, MD Perrigo החברה המארגנת Sanofi Organizing Company א.מ.
    [Show full text]
  • Noa Yekutieli
    NOA YEKUTIELI Born in 1989 in the USA. Lives and works in Tel-Aviv and Los Angeles. Selected Solo Exhibitions 2019​ Kunstverein Augsburg, Germany (upcoming) 2019 ​Track 16 Gallery, Los Angeles, USA (upcoming) 2018​ Modern Portrait, New Position, Art Cologne, with Sabine Knust Galerie, Cologne, Germany 2017​ The Other Side, Public Art Installation, Los Angeles, USA 2017 ​Meeting Place, Galerie Sabine Knust, Munich, Germany 2017 ​Fractured Water, Israeli-Palestinian Pavilion, Nakanojo Biennale, Nakanojo, Japan 2015​ Transitions, Open Contemporary Art Center, Taipei, Taiwan 2015 ​Particles, Treasure Hill Artist Village, Taipei, Taiwan 2015 ​Around The Cracks, Sommer Frische Kunst, Bad Gastein, Austria 2015 ​While They Were Moving, They Were Moved, Gordon ll Gallery, Tel Aviv, Israel 2015 ​Reflecting On Shadows, Artist House, Tel Aviv, Israel 2015 ​Uncontainable, Janco Dada Museum, Ein Hod, Israel 2015 ​What Doesn't Bend Breaks, Gallery Schimming, Hamburg, Germany 2015 ​The Magnifying Glass and the Telescope, p/art, Hamburg, Germany 2014​ Through The Fog, The Distance, Wilfrid Museum, Kibbutz Hazorea, Israel 2013​ Between All Our Intentions, Dwek Gallery, Mishkenot Sha’ananim, Jerusalem, Israel 2013 ​Incorporeal Reality, with Yael Balaban, Marina Gisich Gallery, St. Petersburg, Russia 2013 ​1952, Special installation project, Fresh Paint art fair, Tel-Aviv, Israel 2013 ​1952, Givat Haim Gallery, Givat Haim Ehud, Israel 2013 ​A Document of a Passing Moment, Artstation Gallery, Tel-Aviv, Israel 2012​ Baggage, Al Ha'tzuk Gallery, Netanya, Israel
    [Show full text]
  • ARTICLES Israel's Migration Balance
    ARTICLES Israel’s Migration Balance Demography, Politics, and Ideology Ian S. Lustick Abstract: As a state founded on Jewish immigration and the absorp- tion of immigration, what are the ideological and political implications for Israel of a zero or negative migration balance? By closely examining data on immigration and emigration, trends with regard to the migration balance are established. This article pays particular attention to the ways in which Israelis from different political perspectives have portrayed the question of the migration balance and to the relationship between a declining migration balance and the re-emergence of the “demographic problem” as a political, cultural, and psychological reality of enormous resonance for Jewish Israelis. Conclusions are drawn about the relation- ship between Israel’s anxious re-engagement with the demographic problem and its responses to Iran’s nuclear program, the unintended con- sequences of encouraging programs of “flexible aliyah,” and the intense debate over the conversion of non-Jewish non-Arab Israelis. KEYWORDS: aliyah, demographic problem, emigration, immigration, Israel, migration balance, yeridah, Zionism Changing Approaches to Aliyah and Yeridah Aliyah, the migration of Jews to Israel from their previous homes in the diaspora, was the central plank and raison d’être of classical Zionism. Every stream of Zionist ideology has emphasized the return of Jews to what is declared as their once and future homeland. Every Zionist political party; every institution of the Zionist movement; every Israeli government; and most Israeli political parties, from 1948 to the present, have given pride of place to their commitments to aliyah and immigrant absorption. For example, the official list of ten “policy guidelines” of Israel’s 32nd Israel Studies Review, Volume 26, Issue 1, Summer 2011: 33–65 © Association for Israel Studies doi: 10.3167/isr.2011.260108 34 | Ian S.
    [Show full text]
  • Around the Globe Israeli Medical Association No
    Around The Globe Israeli Medical Association No. 16 | June 2011 A word from the chairman Dear Friends, vices to those from evacuated areas who and opinions on professional issues as e are happy to present you had no access to medical care. well as on the unbalanced exposures and with another issue of ‘IMA I had the pleasure of travelling to discussions of political topics concerning around the Globe’ where the UK, and met our Jewish Medical As- Israel in the British scientific Journals. I Wyou can read about the work of the IMA sociation - UK Chapter. I met medical would like to thank the IMA UK Chapter in Israel and abroad. In February, the students affiliated with the IMA and re- for their generous hospitality during my IMA publically announced our launch viewed Neuroscience practice in Israel. time in London. of “a mission to save public medicine,” I attended an evening event hosted by I am excited to inform you that we demanding additional manpower, more Dr. David Katz, the executive chairman have been invited to present Israeli and beds in hospitals, and incentive pay to of the UK Chapter, which was attended Jewish Medicine at the European Par- draw more physicians to the periphery by the local IMA-WF committee group. liament this November. I would like to and to multiple specialties suffering Throughout the evening we discussed thank Dr. Willie Lipschutz, the executive from physician shortages. This struggle issues related to how Israeli medicine chairman of the Belgian Chapter of IMA- is for health and medicine in Israel and is portrayed in British medical journals, WF for organizing the event.
    [Show full text]
  • Dear Colleagues, It Is Our Pleasure to Invite You to the Annual Meeting Of
    Dear Colleagues, It is our pleasure to invite you to the Annual Meeting of the Israel Neurosurgical Society which will be held at the Galilion Hotel, Israel. Although the main focus of the meeting will be Brain Tumors, the organizers will be happy to consider interesting talks on related subjects. Confirmed speakers to date that will share their experiences and update us in the latest developments include: Prof. Volker A. Coenen Dept. of Stereotactic and Functional Neurosurgery, University of Freiberg; Neurosurgery Clinic, Freiberg, Germany Prof. Garth Rees Cosgrov Dept. of Neurological Surgery, Brigham and Women's Hospital, Boston, MA, USA Prof. Hans Henkes Neuroradiological Clinic, Katharinenhospital, Stuttgart, Germany Prof. Robert H. Rosenwasser Dept. of Neurological Surgery, Jefferson Hospital for Neuroscience, Philadelphia, PA, USA As in previous meetings, we hope that this event will provide the opportunity to reconnect and meet with colleagues and to strengthen professional and personal ties among our members. We hope that you will be able to join us. Sincerely, Prof. Yigal Shoshann Prof. Mony Benifla Dr. Racheli Grossman President Secretary Treasurer 1 TENTATIVE TIMETABLE Wednesday, May 13, 2020 Light Lunch Afternoon Sessions Dinner Evening Social Event Thursday, May 14, 2020 Morning Sessions Lunch Afternoon Sessions Dinner Evening Social Event Friday, May 15, 2020 Morning Sessions Afternoon Sessions End and Light Lunch Meeting Secretariat Target Conferences Ltd. PO Box 51227, Tel Aviv 6713818, Israel Tel: +972 3 5175150, Fax: +972 3 5175155 e-mail: [email protected] www.israelneurosurgery.com 2 SCIENTIFIC ADVISORY COMMITTEE ON FUNCTIONAL NEUROSURGERY AND EPILEPSY Zvi Israel - Lead Advisor Dept. of Neurosurgery, Hadassah Hebrew University Medical Center, Jerusalem Roberto Spiegelmann Dept.
    [Show full text]
  • Mission Report Ref.Code: 9N15novkq0w0ggs4ogcwc8g44
    Brieftrace Mission Report Ref.code: 9n15novkq0w0ggs4ogcwc8g44 Brieftrace Ltd. Medinat Ha-Yehudim 85 4676670 Herzeliya Mission Report Israel 04.04.18 clalit Status: Success Generated: Wed, 04 Apr 18 09:50:31 +0300 Shipment Configuration Started at: 04-Apr-2018 07:30 Asia/Jerusalem Airway bill: N/A Finished at: 04-Apr-2018 09:50 Asia/Jerusalem Devices: c4be84e73383 (c4be84e73383) Current stage: Completed User name: Shai Temperatures Highest: 5.41 °C Allowed: 8 °C Report interval: 5 minutes Average: 4.29 °C Data sampling rate: 5 minutes Lowest: 3.63 °C Allowed min: 2 °C Datapoints: 22 Transmissions: 22 Road Story Page 1 of 3 Generated at 2018-04-04 06:50:31 UTC Brieftrace Mission Report Ref.code: 9n15novkq0w0ggs4ogcwc8g44 Report Data 13 ° 12 ° 11 ° 10 ° 9 ° Allowed high: 8° C 8 ° C 7 ° ° High e r 6 ° Max: 5.41° C u t a 5 ° r Low e p 4 ° Min: 3.63° C m e 3 ° T Allowed low: 2° C 2 ° 1 ° 0 ° -1 ° -2 ° -3 ° 07:30 07:45 08:00 08:15 08:30 08:45 09:00 09:15 09:30 09:45 Date and time. All times are in Asia/Jerusalem timezone. brieftrace.com Tracker Time Date Temp°CAlert? RH % Location Control Traceability c4be84e73383 07:30 04-04-2018 4.26 79.65 Ha-Matekhet St 17, Kadima Zoran, Israel 636158 dfb902 c4be84e73383 07:36 04-04-2018 4.24 79.75 Ha-Matekhet St 17, Kadima Zoran, Israel 636161 b23bc8 c4be84e73383 07:43 04-04-2018 4.21 79.75 Ha-Matekhet St 17, Kadima Zoran, Israel 636167 c1c01c c4be84e73383 07:49 04-04-2018 4.18 79.85 Ha-Matekhet St 17, Kadima Zoran, Israel 636176 4a3752 c4be84e73383 07:56 04-04-2018 4.21 79.85 Ha-Matekhet St 17, Kadima
    [Show full text]
  • Aliyah and Settlement Process?
    Jewish Women in Pre-State Israel HBI SERIES ON JEWISH WOMEN Shulamit Reinharz, General Editor Joyce Antler, Associate Editor Sylvia Barack Fishman, Associate Editor The HBI Series on Jewish Women, created by the Hadassah-Brandeis Institute, pub- lishes a wide range of books by and about Jewish women in diverse contexts and time periods. Of interest to scholars and the educated public, the HBI Series on Jewish Women fills major gaps in Jewish Studies and in Women and Gender Studies as well as their intersection. For the complete list of books that are available in this series, please see www.upne.com and www.upne.com/series/BSJW.html. Ruth Kark, Margalit Shilo, and Galit Hasan-Rokem, editors, Jewish Women in Pre-State Israel: Life History, Politics, and Culture Tova Hartman, Feminism Encounters Traditional Judaism: Resistance and Accommodation Anne Lapidus Lerner, Eternally Eve: Images of Eve in the Hebrew Bible, Midrash, and Modern Jewish Poetry Margalit Shilo, Princess or Prisoner? Jewish Women in Jerusalem, 1840–1914 Marcia Falk, translator, The Song of Songs: Love Lyrics from the Bible Sylvia Barack Fishman, Double or Nothing? Jewish Families and Mixed Marriage Avraham Grossman, Pious and Rebellious: Jewish Women in Medieval Europe Iris Parush, Reading Jewish Women: Marginality and Modernization in Nineteenth-Century Eastern European Jewish Society Shulamit Reinharz and Mark A. Raider, editors, American Jewish Women and the Zionist Enterprise Tamar Ross, Expanding the Palace of Torah: Orthodoxy and Feminism Farideh Goldin, Wedding Song: Memoirs of an Iranian Jewish Woman Elizabeth Wyner Mark, editor, The Covenant of Circumcision: New Perspectives on an Ancient Jewish Rite Rochelle L.
    [Show full text]
  • 0201 Haplotype on the Risk for Multiple Sclerosis in Diverse Arab Populations in Israel
    Genes and Immunity (2010) 11, 423–431 & 2010 Macmillan Publishers Limited All rights reserved 1466-4879/10 www.nature.com/gene ORIGINAL ARTICLE Opposing effects of the HLA-DRB1*0301-DQB1*0201 haplotype on the risk for multiple sclerosis in diverse Arab populations in Israel G Benedek1,6, T Paperna2,6, N Avidan2, I Lejbkowicz2, JR Oksenberg3, J Wang3, C Brautbar1,4, S Israel4 and A Miller2,5, for the Israeli MS Genetics group7 1The Lautenberg Center for Immunology, Hebrew University Hadassah Medical School, Jerusalem, Israel; 2Faculty of Medicine, Rappaport Research Institute, Technion–Israel Institute of Technology, Haifa, Israel; 3Department of Neurology, University of California, San Francisco, CA, USA; 4Tissue Typing and Immunogenetics Unit, Hadassah Medical Center, Jerusalem, Israel and 5Division of Neuroimmunology and Multiple Sclerosis Center, Carmel Medical Center, Haifa, Israel Different multiple sclerosis (MS) prevalence rates were reported for Muslim and Christian Arabs in Israel. In this study, we evaluated whether associations of human leukocyte antigen (HLA) genes with MS may contribute to this prevalence difference. DNA samples from Israeli Arab MS patients (n ¼ 109) and controls (n ¼ 132) were typed for HLA class I (HLA-A, -B and -C) and II (HLA-DRB1 and -DQB1) genes. Global comparisons of HLA allele frequencies revealed significant differences between Christians and Muslims; therefore, case–control analyses were stratified by religious affiliation. Disease characteristics of Muslim and Christian Arab MS patients were similar to those reported for European populations. Opposing association signals with MS were observed for alleles composing the DRB1*0301-DQB1*0201 haplotype: positive association of the HLA- DRB1*0301 allele in Muslims (PBonferroni ¼ 0.004, odds ratio (OR) ¼ 3.07), and negative association in Christian Arabs (PBonferroni ¼ 0.01, OR ¼ 0.12), with similar results obtained for HLA-DQB1*0201.
    [Show full text]
  • When Are Foreign Volunteers Useful? Israel's Transnational Soldiers in the War of 1948 Re-Examined
    This is a repository copy of When are Foreign Volunteers Useful? Israel's Transnational Soldiers in the War of 1948 Re-examined. White Rose Research Online URL for this paper: http://eprints.whiterose.ac.uk/79021/ Version: WRRO with coversheet Article: Arielli, N (2014) When are Foreign Volunteers Useful? Israel's Transnational Soldiers in the War of 1948 Re-examined. Journal of Military History, 78 (2). pp. 703-724. ISSN 0899- 3718 Reuse Items deposited in White Rose Research Online are protected by copyright, with all rights reserved unless indicated otherwise. They may be downloaded and/or printed for private study, or other acts as permitted by national copyright laws. The publisher or other rights holders may allow further reproduction and re-use of the full text version. This is indicated by the licence information on the White Rose Research Online record for the item. Takedown If you consider content in White Rose Research Online to be in breach of UK law, please notify us by emailing [email protected] including the URL of the record and the reason for the withdrawal request. [email protected] https://eprints.whiterose.ac.uk/ promoting access to White Rose research papers Universities of Leeds, Sheffield and York http://eprints.whiterose.ac.uk/ White Rose Research Online URL for this paper: http://eprints.whiterose.ac.uk/79021/ Paper: Arielli, N (2014) When are foreign volunteers useful? Israel's transnational soldiers in the war of 1948 re-examined. Journal of Military History, 78 (2). 703 - 724. White Rose Research Online [email protected] When are Foreign Volunteers Useful? Israel’s Transnational Soldiers in the War of 1948 Re-examined Nir Arielli Abstract The literature on foreign, or “transnational,” war volunteering has fo- cused overwhelmingly on the motivations and experiences of the vol- unteers.
    [Show full text]
  • The Right Atrium of Patients with Various Heart Diseases Retain Progenitor Cells with Regenerative Capacity
    S7 - Prognosis and Outcome in Heart Failure The Right Atrium of Patients with Various Heart Diseases Retain Progenitor Cells with Regenerative Capacity Ayelet Itzhaki-Alfia 1, Jonathan Leor 1,Shiri Netser1, Leonid Sternik 2, Dan Spiegelstein 2, David Mishaly 2, Jacob Lavee 2, Ehud Raanani 2,Barbash Israel M3 1 Neufeld Cardiac Research Institute, Sackler Faculty of Medicine,Tel-Aviv University, 2 Department of Cardiothoracic Surgery, 3 Neufeld Cardiac Research Institute, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel The 55th Annual Conference of the I.H.S and the I.S.C.S 37 S7 - Prognosis and Outcome in Heart Failure The Impact of the NT-proBNP Assay in the Emergency Department on the Diagnosis of Heart Failure and on Outcomes in Patients Admitted for Dyspnea: A Prospective Randomized Placebo-controlled Double-center Trial (BNP4EVER) Simcha Meisel 1, Margarita Medvedovski 2, Moshe Sharist 3, Jalal Ashkar 2,Pavel Pschianski2, Michael Glikson 4, Shmuel Bar Haim 3, Michael Shochat 1, David Blondheim 1, Avraham Shotan 1 1 Heart Institute, Hillel Yaffe Medical Center, 2 Emergency Department, Hillel Yaffe Medical Center, Hadera, 3 Emergency Department, Assaf Harofeh Medical Center, Zerifin, 4 Heart Institute, Chaim Sheba Medical Center, Hadera, Israel The 55th Annual Conference of the I.H.S and the I.S.C.S 38 S7 - Prognosis and Outcome in Heart Failure Echocardiographic and Plasma N-Terminal Pro-B Type Natriuretic Peptide Evaluation During Pregnancy in Patients with Preexisting Dilated Cardiomyopathy Alex Blatt 1,Ilya Litovchik1, Ricardo
    [Show full text]
  • Scientific Program
    The 63th Annual Conference of the Israel Heart Society in association with the Israel Society of Cardiothoracic Surgery April 12-13 • 2016 • Tel Aviv, Israel SCIENTIFIC PROGRAM Paragon Israel (Dan Knassim) Paragon Tel/Fax:03-5767730/7 Israel (Dan Knassim) a Paragon Group Company [email protected] TUESDAY, APRIL 12, 2016 08:30-10:00 Interventional Cardiology I Hall A Chairs: Ariel Finkelstein, Ran Kornowski, Israel 08:30 Effect of Diameter of Drug-Eluting Stents Versus Bare-Metal Stents on Late Outcomes: a propensity score-matched analysis Amos Levi1,2, Tamir Bental1,2, Hana Veknin Assa1,2, Gabriel Greenberg1,2, Eli Lev1,2, Ran Kornowski1,2, Abid Assali1,2 1Cardiology, Rabin Medical Center, Israel 2Sackler Faculty of Medicine, Tel Aviv University, Israel 08:41 Percutaneous Valve-in-Valve Implantation for the Treatment of Aortic, Mitral and Tricuspid Structural Bioprosthetic Valve Degeneration Uri Landes1, Abid Assali1, Ram Sharoni1,2, Hanna Vaknin-Assa1, Katia Orvin1, Amos Levi1, Yaron Shapira1, Shmuel Schwartzenberg1, Ashraf Hamdan1, Tamir Bental1, Alexander Sagie1, Ran Kornowski1 1Department of Cardiology, Rabin Medical Center, Tel Aviv, Israel 2Department of Cardiac Surgery, Rabin Medical Center, Tel Aviv, Israel 08:52 Temporal Trends in Transcatheter Aortic Valve Implantation in Israel 2008-2014: Patient Characteristics, Procedural Issues and Clinical Outcome Uri Landes1, Alon Barsheshet1, Abid Assali1, Hanna Vaknin-Assa1, Israel Barbash3, Victor Guetta3, Amit Segev3, Ariel Finkelstein2, Amir Halkin2, Jeremy Ben-Shoshan2,
    [Show full text]